-
Mashup Score: 0
BOSTON — More than 40% of patients with difficult-to-treat pathogens were prescribed older, generic agents despite the FDA approval of several new gram-negative antibiotics, findings showed.According to Sameer S. Kadri-Rodriguez, MD, MS, a staff clinician at the NIH, and colleagues, eight next-generation gram-negative antibiotics have been approved by the FDA since 2014, which include:
Source: www.healio.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
BOSTON — More than 40% of patients with difficult-to-treat pathogens were prescribed older, generic agents despite the FDA approval of several new gram-negative antibiotics, findings showed.According to Sameer S. Kadri-Rodriguez, MD, MS, a staff clinician at the NIH, and colleagues, eight next-generation gram-negative antibiotics have been approved by the FDA since 2014, which include:
Source: www.healio.comCategories: General Medicine News, General NewsTweet
More than 40% of patients with difficult-to-treat pathogens were prescribed older, generic agents despite the FDA approval of several new gram-negative antibiotics, research at #IM2024 showed 💊 #primarycare Read more on the data here: https://t.co/YzLyn4eN3g